EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recurrent disruption of tumour suppressor genes in cancer by somatic mutations in cleavage and polyadenylation signals

Yaroslav Kainov iD, Fursham Hamid iD, Eugene V Makeyev iD

eLife · 2024

DOI: 10.7554/elife.99040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Yaroslav Kainov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Developmental Neurobiology, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Neoplasms, Genes, Tumor Suppressor, Mutation, Polyadenylation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The expression of eukaryotic genes relies on the precise 3'-terminal cleavage and polyadenylation of newly synthesized pre-mRNA transcripts. Defects in these processes have been associated with various diseases, including cancer. While cancer-focused sequencing studies have identified numerous driver mutations in protein-coding sequences, noncoding drivers – particularly those affecting the cis-elements required for pre-mRNA cleavage and polyadenylation – have received less attention. Here, we systematically analysed somatic mutations affecting 3'UTR polyadenylation signals in human cancers using the Pan-Cancer Analysis of Whole Genomes (PCAWG) dataset. We found a striking enrichment of cancer-specific somatic mutations that disrupt strong and evolutionarily conserved cleavage and polyadenylation signals within tumour suppressor genes. Further bioinformatics and experimental analyses conducted as a part of our study suggest that these mutations have a profound capacity to downregulate the expression of tumour suppressor genes. Thus, this work uncovers a novel class of noncoding somatic mutations with significant potential to drive cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGenes, Tumor SuppressorMutationPolyadenylationHumans3' Untranslated RegionsComputational BiologyGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

cancer biologycleavagegeneticsgenomicshumanpolyadenylationsomatic mutationstumour suppressor

Substanzen

3' Untranslated Regions

Autor:innen und Institutionen

  • Centre for Developmental Neurobiology, King's College London, London, United Kingdom.
  • Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.

ORCID-Profile: Yaroslav Kainov, Fursham Hamid, Eugene V Makeyev

Förderung

  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Kainov, Y., Hamid, F., & Makeyev, E. V. (2024). Recurrent disruption of tumour suppressor genes in cancer by somatic mutations in cleavage and polyadenylation signals. eLife. https://doi.org/10.7554/elife.99040

Vancouver

Kainov Y, Hamid F, Makeyev EV. Recurrent disruption of tumour suppressor genes in cancer by somatic mutations in cleavage and polyadenylation signals. eLife. 2024. doi:10.7554/elife.99040

BibTeX
@article{Kainov2024,
  author = {Kainov, Yaroslav and Hamid, Fursham and Makeyev, Eugene V},
  title = {Recurrent disruption of tumour suppressor genes in cancer by somatic mutations in cleavage and polyadenylation signals},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.99040}
}
Kostenlos starten →